Cargando…
Gastric Cancer and the Immune System: The Key to Improving Outcomes?
SIMPLE SUMMARY: Gastric cancer (GC) is a lethal form of cancer usually arising from the inner mucosa layer of the stomach. The treatment options for gastric cancer often includes surgery and chemotherapy, but recurrent or advanced disease remains difficult to cure. In aiming to improve outcomes, new...
Autores principales: | Keshavjee, Sara H., Moy, Ryan H., Reiner, Steven L., Ryeom, Sandra W., Yoon, Sam S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739366/ https://www.ncbi.nlm.nih.gov/pubmed/36497422 http://dx.doi.org/10.3390/cancers14235940 |
Ejemplares similares
-
The Present and Future of Neoadjuvant and Adjuvant Therapy for Locally Advanced Gastric Cancer
por: Koerner, Anna S., et al.
Publicado: (2023) -
KRAS activation in gastric cancer stem-like cells promotes tumor angiogenesis and metastasis
por: Yoon, Changhwan, et al.
Publicado: (2023) -
E-cadherin and K-ras: implications of a newly developed model of gastric cancer
por: Till, Jacob E., et al.
Publicado: (2017) -
PIK3R3, part of the regulatory domain of PI3K, is upregulated in sarcoma stem-like cells and promotes invasion, migration, and chemotherapy resistance
por: Yoon, Changhwan, et al.
Publicado: (2021) -
PI3K/Akt pathway and Nanog maintain cancer stem cells in sarcomas
por: Yoon, Changhwan, et al.
Publicado: (2021)